Congruence Therapeutics

For two decades, BIOTECanada’s Gold Leaf Awards have celebrated the outstanding individuals and companies driving innovation and excellence in the Canadian biotechnology sector. We are deeply honored that our CEO has received the prestigious “Game-Changing Industry Leadership Award.” This recognition fuels our commitment to advancing the global biotech industry and making a lasting impact on healthcare and innovation. More details can be found here: https://lnkd.in/eez5Mti6 #Biotech #Innovation #DrugDiscovery #AI #BIOTECanada

Congruence Therapeutics will participate in the 2024 Barclays Biotech 1x1 Private Company Symposium, being held in a virtual format Wednesday, August 7, 2024.   Read more here: https://lnkd.in/gcqWSg9j #BarclaysBiotech #Biotechnology

We're #hiring a new DMPK Senior Scientist in Greater Montreal, Quebec. Apply today or share this post with your network.

Congruence Therapeutics is thrilled to sponsor the inaugural #GBA1 meeting, taking place this week at the The Neuro (Montreal Neurological Institute-Hospital), a research and medical center affiliated with McGill University and dedicated to neuroscience training and clinical care #Neuro. The meeting will serve as a unique platform to advance the understanding and treatment of GBA1-associated neurodegenerative diseases. Congruence is also pleased to announce the acceptance of its poster for presentation at the conference. The poster highlights continued advancement of Congruence’s discovery-stage program directed to GBA-driven Parkinson’s Disease. We look forward to sharing our progress with meeting attendees. For more information click here: https://bit.ly/4cs1Xhn #GBA1 #Parkinsons #neuro

Congruence Therapeutics is presenting at the Chemical Computing Group #UGM and Conference 2024, taking place June 25-28 in our hometown of Montreal. The event consists of workshops, scientific presentations, and a poster session. We will showcase our computational drug discovery engine and how we are leveraging it to build an exciting pipeline of small molecule correctors for diseases of protein misfolding. Come engage with us! Learn more here: https://bit.ly/3zkH21e #UGM #CCG #AI #ML

Congruence Therapeutics is proud that several of its team members will attend the Machine Learning for Drug Discovery Summer School, sponsored by #Mila, a world-renowned AI-hub and one of our collaborators. Our participants will receive hands-on training and present on the application of machine learning in drug discovery.     Click here for details:  https://bit.ly/3XpvVhM   #MoML2024 #Mila #AI #ML

Our Chief Business Officer, Frank Taffy, will be at #BIO2024. We invite you to connect with us! #biotech #innovation #drugdiscovery #AI #ML